Monument Biosciences is dedicated to bringing forward the next generation of disease modifying drugs for Alzheimer’s Disease and Related Dementias (ADRD)
Monument Biosciences is dedicated to bringing forward the next generation of disease modifying drugs for Alzheimer’s Disease and Related Dementias (ADRD). The company focuses on advancing new AD targets through diverse therapeutic modalities and potential combination therapy, leveraging human patient genetics and translational biomarkers.